Pharmafile Logo

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

- PMLiVE

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For the >7,000 distinct rare conditions, around 70% of which begin in childhood, many patients and families face common challenges including delayed diagnosis, fragmented care, and significant social and financial burdens. A recent World Economic Forum white paper, “Making Rare Diseases Count: How Better Data Can Unlock a Multi‑Trillion‑Dollar Opportunity,” argues that these conditions represent not only a profound human challenge, but also one of the largest untapped opportunities in global health and economic resilience.

Access the whitepaper here

The paper highlights the massive but largely invisible cost of rare diseases, estimated at between USD 7.2 and 8.6 trillion each year, and calls for stronger data systems to make this burden visible and actionable. Its roadmap centres on five priorities: defining a minimum dataset across countries, strengthening patient registries, expanding screening and diagnostic capacity, enabling trusted data sharing, and using AI and digital tools to close evidence gaps.

This agenda builds on growing policy momentum, including the pivotal 2025 World Health Assembly resolution on rare diseases, sponsored by Egypt and Spain and co‑sponsored by 39 other UN Member States, which includes a call to member states to support education for healthcare providers on rare diseases. Shortening the diagnostic odyssey through education is crucial: today, only 19% of physicians feel confident diagnosing rare diseases, and many patients wait years for an accurate diagnosis.

Access the whitepaper here

Medscape, as a contributor to the WEF paper, brings evidence that targeted professional education can help close this gap. Its rare disease programmes, informed by global survey data and real‑world outcomes, have shown that clinicians who participate in accredited training as compared with similar cohorts who do not, order significantly more genetic tests and code more often for rare diseases. This suggests that education may help shorten the diagnostic journey in real world practice. Medscape data also reveal striking gaps in physician awareness of rare disease prevalence, with a majority reporting that they never or rarely (defined as 1-2x per year), see rare disease patients despite evidence suggesting they should be seeing several per week.

With a community of >13 million healthcare professionals and the largest dedicated library of rare disease education, Medscape is positioned to translate the WEF’s data‑driven roadmap into everyday clinical practice. By aligning better data with focused education, the rare‑disease community can turn global recognition into earlier diagnoses, better access to care, and measurable value for patients, health systems, and societies worldwide.

To learn more about how Medscape Education is tackling the rare disease burden through precision education, please contact S Christy Rohani‑Montez.

Sign up to Medscape Education’s Rare Disease Newsletter here.

About Medscape Education

Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

TECHNOLOGY TRENDS AND THE FUTURE OF MEDICAL DEVICES

A MEDSCAPE DIGITAL HEALTH AND INNOVATION EVENT

Device Technology and Innovations

The world of medical device technology is constantly evolving. From wearable devices to diagnostic technology, clinicians have more options than ever for monitoring and assessing their patients' health. The accessibility...

The Power of AI in Medical Education

Artificial intelligence (AI) is a rapidly growing field with many applications in the world of medicine, including continuing medical education. Ritu Kumar, Medscape lead data scientist, explains how Medscape Education...

Connect to the conversation around mental health: A spotlight on physician burnout

For more than 2 years, the COVID-19 pandemic has put emphasis on an issue that has long affected healthcare workers and physicians -- burnout. Every year, Medscape surveys thousands of...

MEDSCAPE EDUCATION: The Human Story in Virtual Patient Simulation

WHAT'S THE STORYStories are shared experiences, where meaning-centered approaches and coping strategies ascribe cultural meaningto events and emotions; a way to merge the individual and the collective experience into the...

It’s a Medscape wrap for EHA2022

EHA2022 Hybrid Congress has now come to a close with the Thematic Days finishing last week. The Medscape team were delighted to connect with so many physicians, colleagues and supporters...

Part 4 of 4, of the Medscape video interview series

Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients...

Part 3 of the Medscape video series #EHA

Ahead of  Europe’s largest hematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer, interviews Dr. Naval Daver on the most important abstracts to look out for in Myeloid and...

Part 2 of the Medscape video interview series

Ahead of Europe’s largest haematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer interviews Dr. John Gribben on the most important abstracts to look out for in CLL and the...

A Medscape Oncology exclusive preview

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. We are the largest medical education provider, delivering precision education for actionable outcomes across 30+ specialties in...